Literature DB >> 16697686

Differences in gene expression levels and in enzymatic qualities account for the uneven contribution of superoxide dismutases SodCI and SodCII to pathogenicity in Salmonella enterica.

Nara Figueroa-Bossi1, Serena Ammendola, Lionello Bossi.   

Abstract

Most Salmonella enterica serovars produce two periplasmic [Cu,Zn] superoxide dismutases, SodCI, which is prophage encoded, and SodCII, encoded by a conserved chromosomal gene. Both enzymes were proposed to enhance Salmonella virulence by protecting bacteria against products of macrophage oxidative burst. However, we previously found SodCI, but not SodCII, to play a role during mouse infection by S. enterica serovar Typhimurium. Here we have extended these findings to another serovar of epidemiological relevance: sv Enteritidis. In both serovars, the dominant role of SodCI in virulence correlates with its higher levels in bacteria proliferating in mouse tissues, relative to SodCII. To analyze the basis of these differences, the coding sequences of sodCI and sodCII genes were exchanged with the reciprocal 5'-regions (in serovar Typhimurium). The accumulation patterns of the two proteins in vivo were reversed as a result, indicating that the regulatory determinants lie entirely within the regions upstream from the initiation codon. In the construct with the sodCI gene fused to the sodCII 5'-region, SodCI contribution to virulence was reduced but remained significant. Thus, both, high-level expression and some unidentified qualities of the enzyme participate in the phenotypic dominance of SodCI over SodCII in Salmonella pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697686     DOI: 10.1016/j.micinf.2006.01.015

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  The YfgL lipoprotein is essential for type III secretion system expression and virulence of Salmonella enterica Serovar Enteritidis.

Authors:  Yann Fardini; Kamel Chettab; Olivier Grépinet; Sandrine Rochereau; Jérôme Trotereau; Philippa Harvey; Maïté Amy; Elisabeth Bottreau; Nat Bumstead; Paul A Barrow; Isabelle Virlogeux-Payant
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

2.  Microbiological analysis of nontyphoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in HIV/AIDS patients in San Diego, California.

Authors:  Michael J Preziosi; Sean M Kandel; Donald G Guiney; Sara H Browne
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

3.  Protecting against antimicrobial effectors in the phagosome allows SodCII to contribute to virulence in Salmonella enterica serovar Typhimurium.

Authors:  Byoungkwan Kim; Susan M Richards; John S Gunn; James M Slauch
Journal:  J Bacteriol       Date:  2010-02-12       Impact factor: 3.490

4.  Regulatory and structural differences in the Cu,Zn-superoxide dismutases of Salmonella enterica and their significance for virulence.

Authors:  Serena Ammendola; Paolo Pasquali; Francesca Pacello; Giuseppe Rotilio; Margaret Castor; Stephen J Libby; Nara Figueroa-Bossi; Lionello Bossi; Ferric C Fang; Andrea Battistoni
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

5.  Insertion hot spot for horizontally acquired DNA within a bidirectional small-RNA locus in Salmonella enterica.

Authors:  Roberto Balbontín; Nara Figueroa-Bossi; Josep Casadesús; Lionello Bossi
Journal:  J Bacteriol       Date:  2008-04-04       Impact factor: 3.490

Review 6.  Phages and their potential to modulate the microbiome and immunity.

Authors:  Sara Federici; Samuel P Nobs; Eran Elinav
Journal:  Cell Mol Immunol       Date:  2020-09-08       Impact factor: 11.530

7.  Regulatory and structural properties differentiating the chromosomal and the bacteriophage-associated Escherichia coli O157:H7 Cu, Zn superoxide dismutases.

Authors:  Melania D'Orazio; Raffaella Scotti; Laura Nicolini; Laura Cervoni; Giuseppe Rotilio; Andrea Battistoni; Roberta Gabbianelli
Journal:  BMC Microbiol       Date:  2008-10-01       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.